Experimental Drug Proves Superior to Eculizumab as a Treatment for Paroxysmal Nocturnal Hemoglobinuria
source: pixabay.com

Experimental Drug Proves Superior to Eculizumab as a Treatment for Paroxysmal Nocturnal Hemoglobinuria

According to a story from BioSpace, the biopharmaceutical company Apellis Pharmaceuticals, Inc., has recently announced the results of its phase 3 clinical trial, which was testing the company's investigational drug…

Continue Reading Experimental Drug Proves Superior to Eculizumab as a Treatment for Paroxysmal Nocturnal Hemoglobinuria
Is There a Link Between Amyotrophic Lateral Sclerosis and Physical Trauma?
source: pixabay.com

Is There a Link Between Amyotrophic Lateral Sclerosis and Physical Trauma?

According to a story from News Amed, Rob Burrow gained fame as a star player for the Leeds Rhinos, a professional rugby team. After a distinguished career, Rob retired from…

Continue Reading Is There a Link Between Amyotrophic Lateral Sclerosis and Physical Trauma?
Study Highlights Disparities Between Acromegaly Patients and Their Doctors
source: pixabay.com

Study Highlights Disparities Between Acromegaly Patients and Their Doctors

According to a story from Medscape, a recent study published in the medical journal Pituitary has revealed a significant disconnect between acromegaly patients and their physicians. The study suggests that doctors…

Continue Reading Study Highlights Disparities Between Acromegaly Patients and Their Doctors
Investigative Therapy Puts Seven Olmsted Syndrome Patients in Remission
source: pixabay.com

Investigative Therapy Puts Seven Olmsted Syndrome Patients in Remission

Olmsted syndrome is a rare disease most frequently caused by mutations in TRPV3. For some patients, it is caused by MBTPS2 mutations. It is characterized by palmoplantar keratoderma (PPK) as…

Continue Reading Investigative Therapy Puts Seven Olmsted Syndrome Patients in Remission
Close Menu